Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01868074
Other study ID # 201209787
Secondary ID
Status Active, not recruiting
Phase N/A
First received May 23, 2013
Last updated December 11, 2013
Start date May 2013
Est. completion date August 2014

Study information

Verified date December 2013
Source University of Iowa
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This research is being conducted to determine whether use of an arch-supporting insole during pregnancy prevents alterations in foot structure and lower limb rotational movements. The investigators hypothesize that the arch collapse during pregnancy will be significantly reduced in women randomized to use the supportive insole compared with women randomized to the control group.


Description:

Musculoskeletal impairments are a significant cause of functional limitations and disability in women. Women are at higher risk for osteoarthritis in comparison with men [1] and functional limitations due to arthritis are also more common in women. [2, 3] In addition, women are disproportionately affected (risk compared with men) by knee osteoarthritis (1.8x),[4] greater trochanteric pain syndrome (3.3x),[5] incident hip osteoarthritis[6] and chronic joint pain (1.3x),[7] including foot pain[8] knee pain[9] hip pain[9-12] and low back pain (1.2x).[7, 13] Preventing even a portion of these could avoid functional limitations and disability, enhance quality of life and result in considerable savings.[2] However, the etiology for the increased risk for these musculoskeletal diseases and impairments has not been elucidated.[1] Acute Changes in Foot Structure Are Reported with Pregnancy The disproportionate risk for these musculoskeletal problems may, in part, relate to biochemical and biomechanical changes that occur in a woman's body during pregnancy. For example, hallux valgus deformity, lateral deviation of the great toe often in conjunction with a bunion deformity, occurs in women at nine times the rate of men.[14] Both of these have been linked to reduction in arch height.[15] Body mass increases by an average of 9-13 kg during pregnancy.[16] There is also a seven to ten-fold increase in the relaxin level during pregnancy,[17-19] a peptide hormone produced by the corpus luteum which increases the flexibility and remodeling of collagen in central and peripheral joints in pregnant women.[17, 18, 20-26] Bearing increased weight on joints with increased laxity during pregnancy could potentially lead to permanent changes in the feet.[19, 26-28] Increases in foot length, width, and volume have been reported during pregnancy.[29, 30, 31] In addition to the anatomic changes in the foot, there are also changes in gait pattern during pregnancy.[32-35] Nyska found that the center of pressure on the foot during pregnancy shifts posteriorly to compensate for the increased anterior abdominal mass.[36] The combination of ligamentous laxity in the arch, increased body mass with pregnancy and the shift in the center of pressure towards the posterior part of the foot may potentially contribute to stretching of the ligaments supporting the arch, leading to loss of arch height.

More important than the foot changes that have been reported during pregnancy is the issue that these changes persist following completion of pregnancy. In a self-report study, we found a dose-response relationship between the number of pregnancies and the frequency of a report of a permanent change in foot size in women age 18-45.[37] We then conducted a longitudinal study to determine whether arch height loss both occurs and persists postpartum. Sixty women in their first trimester of pregnancy were enrolled and arch height and function were measured at baseline and approximately 19 weeks postpartum. There was a significant decrease in arch height and arch rigidity index at follow-up, with concomitant increases in foot length and arch drop. This study revealed that, not only was pregnancy associated with a permanent loss of arch height, but also the first pregnancy appeared to be the most significant with a reduction in arch rigidity (p<0.0001) and increases in foot length (p<0.0001), arch drop (p=0.0019) and center of pressure excursion during gait (p=0.0019). These changes in the feet could contribute to the increased risk for subsequent musculoskeletal disorders.

Arch Height Loss Leads to Adverse Biomechanical Changes at Other Joints Consideration of the effect of foot structure on forces and torques at other joints in the lower limb and spine as well as the need for energy generation and absorption by associated soft-tissue structures illustrates the importance of these potential changes. With each step, a series of events occurs that elicits biomechanical effects and compensations throughout the lower limb kinetic chain, in which movement at each joint influences movement at other joints in the chain.[38] Disruption of the complex interactions between skeletal, musculotendinous and ligamentous structures through loss of arch height may predispose to painful musculoskeletal conditions.[39-43] As the initial link in body loading during stance and movement, the feet are "where the rubber hits the road." The arch dynamically deforms to distribute the force, thereby absorbing the rapid impulse of loading. Changes in foot biomechanics that occur with changes in the foot structure alter the normal control of forces propagating from the foot to more proximal lower limb joints and the spine,[44] and contribute to pain in the feet, knees, hips,[41-43] and low back.

Possibly the most common cause of such changes in biomechanics is the loss of arch height. Excessive pronation strains the supporting structures of the foot and tendons that cross the ankle, leads to impaired balance,[45] can strain passive stabilizers such as the Achilles tendon, iliotibial band,[46] and anterior cruciate ligament,[47] and can contribute to permanent impairments in the soft tissue structures in the lower limbs.[47, 48] Thus, excessive pronation has been implicated in numerous musculoskeletal complaints, through pathologically re-distributing the ground reaction force over the foot,[49] changing patellar tracking in the femoral trochlea,[50] changing the angle of pull of muscular stabilizers in the lower limbs, and inducing a functional leg length inequality that alters hip and spine loading.[1] Therefore, there is a need to address this gap in knowledge to inform preventive interventions if there are musculoskeletal sequellae.

Biomechanical Changes Contribute to Musculoskeletal Disease Risk As mentioned previously, the permanent loss of arch height that occurs in about 40% of women with pregnancy leads to excessive pronation of the foot. This foot posture causes increased rotation of the tibia[51] and is communicated across the knee. These torques, in turn, may increase compressive and shear stress on the medial tibiofemoral and lateral patellofemoral compartments of the knee. This is important in light of previous work demonstrating that elevated contact stress is predictive of development of incident symptomatic knee osteoarthritis,[52] and the relative risk for knee replacement surgery increases with the number of pregnancies carried.[53] Closing Knowledge Gaps May Attenuate Musculoskeletal Disease Risk in Women In consideration of the evidence to date that pregnancy leads to a drop in the arch and that loss of the arch may contribute to musculoskeletal disease and disablement, there is a compelling rationale to characterize whether use of arch supports during pregnancy can prevent these adverse changes in foot structure during pregnancy. The proposed study will randomize women to either an arch-supportive insole or a control group(that does not wear insoles) and will measure static and dynamic arch structure in the early part of the first trimester and then again 8 weeks postpartum. Successful completion will inform the extent to which loss of arch height with pregnancy can be ameliorated using a conservative physical medicine intervention. This line of research holds great potential to inform preventive interventions to reduce the disproportionate risk for musculoskeletal disease and disability borne by women.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 70
Est. completion date August 2014
Est. primary completion date September 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Women in their first trimester of pregnancy

- Ages 18 and 40

Exclusion Criteria:

- lower limb joint or spinal surgery

- inflammatory joint or muscle problems such as rheumatoid or psoriatic arthritis

- diabetes

- collagen disorder such as Marfan Syndrome, Ehlers-Danlos Syndrome, Mixed Connective Tissue Disease, or Osteogenesis Imperfecta

- cannot walk without any assistance

- surgeries or have another medical condition that may affect their walking ability

- flat feet (absence of a longitudinal arch)

- inability to return for the follow-up visit 2 months after delivery

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Insole
Custom-molded arch-supporting insole

Locations

Country Name City State
United States University of Iowa Iowa City Iowa

Sponsors (2)

Lead Sponsor Collaborator
University of Iowa Foundation for Physical Medicine and Rehabilitation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Arch Drop Measurement of Arch Drop (Sitting arch height minus standing arch height) using Arch Height Index Measurement System baseline, 8 weeks postpartum No
Secondary Change in Arch Height Index Change in the index of foot arch height when standing. baseline, 8 weeks postpartum No
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Completed NCT02520687 - Effects of Dietary Nitrate in Hypertensive Pregnant Women Phase 1